Salix Pharmaceuticals | Evaluate

November 02, 2016

Speciality pharma biz for sale; one careful owner

October 27, 2016

Drug prices quietly rise as politicians pounce

January 14, 2016

Pfallergan rewrites the takeover record books

October 22, 2015

New Valeant fails to inspire

September 01, 2015

Baffling Valeant strikes for troubled Astra psoriasis project

August 20, 2015

Valeant’s $1bn bill to eat a Sprout

May 28, 2015

IBS now an Actavis vs Valeant game

April 10, 2015

Good times roll in Q1 as mid and small cap winners outnumber losers

April 09, 2015

Mylan anti-chain action as good as confirms Teva interest

March 17, 2015

Valeant’s vanity ends Endo’s endeavour to sally Salix

March 12, 2015

Probably not the Endo the story for Salix

Load More